Search

everythinglearnresearchcommunity

for

Search:↓

A woman's excessive hair growth and high testosterone were caused by a rare ovarian tumor, which was successfully treated with surgery.

The document concludes that hirsutism is the main sign for diagnosing hyperandrogenism, which requires a detailed patient history and physical exam.

Cynoglossum amabile has medicinal potential but poses safety concerns due to liver toxicity.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Ozone therapy might improve cancer treatment and reduce its side effects.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

Gefitinib and Sasam-Kyeongokgo together significantly reduce cancer growth and improve immune response in mice.

KRTAP2-3 could help predict cancer recurrence by identifying specific cancer cells.

Metformin, a diabetes drug, may also help fight cancer, but more research is needed to understand how.

Stopping mitochondrial respiration can prevent brain cancer spread in skin cancer patients, and plant compound β-sitosterol could help achieve this.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

The document concludes that accurate diagnosis and treatment are crucial in dermatology, and it presents various findings on skin conditions and treatments.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Inhaling medicine may reduce side effects and improve treatment for a major lung cancer type.

Abnormal Hedgehog signaling in blood cancers may help tumors grow and resist chemotherapy, suggesting potential for targeted treatments.

The combination treatment showed a higher response rate but no significant survival benefits.

Electric pulse treatments for breast cancer show promise in being safer and more effective, with fewer side effects.

High-dose finasteride may help treat glioblastoma but needs localized delivery for effectiveness.

Sonidegib and vismodegib are similarly effective for advanced basal cell carcinoma, but sonidegib might have a slightly better safety profile.

Short telomeres contribute to aging and cancer, and while telomerase can delay aging, it may also promote cancer.

A specific hair protein variant increases the spread of breast cancer and is linked to worse survival rates.

The Wnt signaling pathway is not a major factor in the development of keratoacanthoma, a type of skin tumor.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

New therapies for Birt–Hogg–Dubé syndrome are being developed based on understanding the FLCN gene's role.

The document concludes that parathyroid diseases have a range of clinical features and outcomes, with some conditions being treatable and others having a high risk of mortality.

CRISPR/Cas9 has improved precision and control but still faces clinical challenges.

Adult female acne treatment should be personalized, considering individual preferences and pregnancy, using various topical and oral medications while managing side effects and resistance.